Olema Pharmaceuticals, Inc.
OLMA
$5.59
-$0.17-2.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.80% | -29.75% | -33.95% | -27.71% | -12.69% |
| Total Depreciation and Amortization | 30.83% | 18.63% | 4.24% | -5.44% | -6.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.67% | 28.54% | 18.46% | -15.46% | -25.45% |
| Change in Net Operating Assets | -101.56% | -4,802.42% | 1,655.86% | 375.81% | 2,720.48% |
| Cash from Operations | -37.81% | -43.76% | -24.63% | -13.63% | -15.04% |
| Capital Expenditure | 100.00% | 96.08% | -- | 8.09% | 49.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.31% | -90.32% | -1,819.16% | -123.16% | -191.98% |
| Cash from Investing | 2.48% | -89.90% | -1,827.97% | -123.63% | -192.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.87% | 87.60% | 106.49% | -81.28% | 5,794.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7,738.55% | -3,822.89% | -- | 130.83% | -- |
| Cash from Financing | 55.61% | 83.23% | 101.49% | -81.20% | 5,788.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 296.95% | 335.07% | 58.22% | -189.97% | -273.18% |